Investor Relations

Sensus Healthcare, Inc. (NASDAQ: SRTS; SRTSW) is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development activities. Sensus has successfully incorporated the SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, the SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients.

FACT SHEET
INVESTOR
PRESENTATION
CONTACT US

LHA Investor Relations
Kim Sutton Golodetz
212 838 3777
kgolodetz@lhai.com

Aug 08, 2019
4:30pm - 5:30pm EDT
June 19, 2019
(This presentation will not be webcast)
May 09, 2019
4:30pm - 5:30pm EDT
Mar 19, 2019
3:30pm PDT